Skip to content

KOLTFARMA: sector benchmark

Where does a company stand against its sector? Every ratio over five fiscal years, with its place among its peers and what that means, ready to print for your client.

Sector benchmark

KOLTFARMA

BE 0823.918.196
NACE 47.730, Retail sale of pharmaceutical products
NACE division 47, Retail trade all sizesfiscal years 2020 to 20242,967 to 41,307 sector peers per ratio

Summary

fiscal year 2024

KOLTFARMA does better than half of its sector on 12 of the 14 ratios compared.

most favourable quarter above the median below the median least favourable quarter
Strongest points
  • EBITDA marginbetter than 85%
  • Return on assetsbetter than 84%
  • Net marginbetter than 81%
Points to watch
  • Days sales outstandingbetter than 37%
  • Debt to equitybetter than 44%

Solvency and debt

How soundly the company is financed.
Solvency
46.9%▲2024

Solvency is above 62% of 41,204 sector peers: more favourable than the median.

Position against the sector improving since 2020.

20202021202220232024
Debt to equity
1.13▼2024

Debt to equity is above 56% of 40,686 sector peers: less favourable than the median.

Position against the sector improving since 2020.

20202021202220232024
Long-term debt ratio
0.19▼2024

The long-term debt ratio is below 59% of 21,483 sector peers: more favourable than the median.

Position against the sector improving since 2020.

20202021202220232024
Interest coverage
9.34▲2024

Interest coverage is above 54% of 36,771 sector peers: more favourable than the median.

Position against the sector improving since 2020.

20202021202220232024

Liquidity

Whether it can pay its short-term bills.
Current ratio
1.94▲2024

The current ratio is above 63% of 41,060 sector peers: more favourable than the median.

Position against the sector improving since 2020.

20202021202220232024
Quick ratio
1.45▲2024

The quick ratio is above 68% of 41,086 sector peers: more favourable than the median.

Position against the sector improving since 2020.

20202021202220232024
Working-capital ratio
41.6%▲2024

The working-capital ratio is above 68% of 41,134 sector peers: more favourable than the median.

Position against the sector improving since 2020.

20202021202220232024

Profitability

What the company earns on its assets and its sales.
Return on equity
35.2%▼2024

Return on equity is above 78% of 33,958 sector peers: in the most favourable quarter.

Position against the sector weakening since 2020.

20202021202220232024
Return on assets
16.5%▲2024

Return on assets is above 84% of 41,307 sector peers: in the most favourable quarter.

Position against the sector stable since 2020.

20202021202220232024
Net margin
6.4%▲2024

The net margin is above 81% of 3,730 sector peers: in the most favourable quarter.

Position against the sector stable since 2020.

20202021202220232024
EBITDA margin
14.7%▲2024

The EBITDA margin is above 85% of 2,967 sector peers: in the most favourable quarter.

Position against the sector stable since 2020.

20202021202220232024
Gross margin
17.3%▼2024

The gross margin is above 64% of 3,661 sector peers: more favourable than the median.

Position against the sector stable since 2021.

20202021202220232024

Working-capital cycle

How long cash is tied up in customers, suppliers and stock.
Days sales outstanding
25days▲2024

Days sales outstanding is above 63% of 3,463 sector peers: less favourable than the median.

Position against the sector weakening since 2020.

20202021202220232024
Days payable outstanding
47days▲2024

Days payable outstanding is above 63% of 3,794 sector peers.

20202021202220232024
Days inventory
37days▼2024

Days inventory is below 57% of 3,384 sector peers: more favourable than the median.

Position against the sector stable since 2021.

20202021202220232024

Source: filed annual accounts (NBB) and main activity (CBE register). Compared per fiscal year with each peer's latest statutory accounts; at least 30 peers per ratio. Prepared on 28 September 2026 via checked.be.